Venetoclax: evidence to date and clinical potential
The emergence of targeted therapy for patients with hematological diseases has permanently altered the therapeutic landscape. Immunochemotherapy regimes are now more and more being replaced by targeted therapies due to superior efficacy and better safety profiles. However, evolution and selection of...
Saved in:
Published in | Drugs in Context Vol. 8; pp. 212574 - 13 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
BioExcel Publishing Ltd
09.10.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!